Anti-sickling agents
The provides compounds for the treatment of sickle-cell disease. In particular, the invention provides 5-membered heterocyclic anti-sickling agents that are highly effective and non-toxic, and methods for their use. The compounds include analogues and derivatives of naturally occurring occurring 5-hydroxymethyl-2-furfuraldehyde, 5-Ethyl-2-furfuraldehyde, 5-Methyl-2-furfuraldehyde, and 2-furfuraldehyde, and prodrug forms of the compound.
1. A method for treating sickle cell disease in a patient in need thereof, comprising the step of administering to said patient a compound of the formula:
where
R1 is CHO or a thiozolidine group of the following formula:
R2, R3 and R4 are the same or different and selected from the group consisting of H, OH, alkyl, halogen and hydroxy-alkyl; R6 and R7=H;
X=O or S;
and wherein said compound is administered in sufficient amount to said patient to ameliorate sickle cell disease, with the proviso that R2,R3 and R4 cannot be H or alkyl at the same time when R1 is CHO and X is O.
2. The method of claim 1 , wherein R2 and R3=H; R4 is H, alkyl or hydroxyalkyl; and the general formula of the compound is:
3. The method of claim 1 , wherein said compound is of the formula:
where R2 and R3=H.
4. The method of claim 1 , wherein said compound is of the formula:
where
R2, R3=H; R4 is H, alkyl or hydroxy-alkyl; R6 and R7=H; and X=O.
5. The method of claim 4 , wherein said compound is of the formula:
6. The method of claim 1 , wherein said compound is selected from the group consisting of a compound of the formula: